跳至主要内容
临床试验/IRCT20090801002266N15
IRCT20090801002266N15招募中3 期

Evaluation the efficacy of Add-on Amantadine to clonidine on severity of opioid withdrawal symptoms.

Esfahan University of Medical Sciences0 个研究点目标入组 86 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
86

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 60 years(—)
性别
All

入选标准

  • Satisfaction to participate in the study
  • Having DSM-V criteria for drug dependence
  • Regular and daily consumption of opium and heroin orally, injected or smoked

排除标准

  • The patient's unwillingness to continue cooperation
  • Occurrence of any medical or moral conflict with the continued presence of the patient in the study
  • Occurrence of physical and mental problems requires special interventions in the management of opioid withdrawal

研究者

相似试验